Loading
Bioforce Nanosciences Holdings, Inc. Stock: price and insider trades · United States
US·Mcap US$75.5M
Bioforce Nanosciences Holdings, Inc.: what insiders have been doing
Insider filings for Bioforce Nanosciences Holdings, Inc. are scarce in the SEC (Form 4) feed, the latest one published on 18 October 2023. This page will fill in as new trades are disclosed. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Insider Decl.
4
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Financial data
as of FY 2025FY ended December 2025 · cache
US$2.25
Analyst consensus
Income statement
RevenueUS$15.3k
Gross profitUS$3.8k25% margin
EBITDA-US$490k-3201% margin
Net income-US$1.3M0.0% margin
Valuation
Beta-0.40
Balance sheet & cash
Market capUS$75.5M
Free Cash Flow-US$65.2k
Profitability & ownership
ROA-2942.4%
% insiders81.0%
% institutions0.0%
Last declaration on 18 October 2023
Declarations4 total
1,470,000 shares0Common StockSEC:0001091818-23-000179:0
500,000 shares0Common StockSEC:0001091818-23-000178:0
20,000 shares0Common StockSEC:0001091818-22-000176:0
10,000 shares0Common StockSEC:0001091818-22-000142:0
4 of 4 declarations
About Bioforce Nanosciences Holdings, Inc.
Bioforce Nanosciences Holdings, Inc. is a company focused on the development of nanoscience technologies. It is listed on NASDAQ under the symbol XNAS.
